Misra DP, et al. Management of Takayasu arteritis. Best Pract Res Clin Rheumatol. 2023;37(1):101826.

Article  PubMed  Google Scholar 

Sawalha AH, et al. Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis. Nat Rev Rheumatol. 2025;21:737–51.

Article  PubMed  Google Scholar 

Watts RA, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022;18(1):22–34.

Article  PubMed  Google Scholar 

Jennette JC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.

Article  CAS  PubMed  Google Scholar 

Jagtap S, et al. Increased mortality rate in Takayasu arteritis is largely driven by cardiovascular disease - a cohort study. Rheumatology (Oxford). 2024;63(12):3337–45.

Article  PubMed  Google Scholar 

Misra DP, et al. The 2022 ACR/EULAR classification criteria for Takayasu arteritis predict mortality better than the 1990 ACR classification criteria. Rheumatology (Oxford). 2024;63(10):e278-80.

Article  PubMed  Google Scholar 

Pugh D, et al. Large-vessel vasculitis Nat Rev Dis Primers. 2022;7(1):93.

Article  PubMed  PubMed Central  Google Scholar 

Kermani TA, et al. Assessment of damage in Takayasu’s arteritis. Rheumatology (Oxford). 2025;64(2):682–9.

Article  PubMed  PubMed Central  Google Scholar 

Misra DP, et al. High prevalent early damage independently predicts future mortality in an inception cohort of Takayasu arteritis. Rheumatology (Oxford). 2025. https://doi.org/10.1093/rheumatology/keaf508.

Article  PubMed  Google Scholar 

Aydin SZ, et al. Assessment of disease activity in Large-vessel Vasculitis: results of an international Delphi exercise. J Rheumatol. 2017;44(12):1928–32.

Article  PubMed  PubMed Central  Google Scholar 

Banerjee S, et al. Effect of treatment on imaging, clinical, and serologic assessments of disease activity in Large-vessel Vasculitis. J Rheumatol. 2020;47(1):99–107.

Article  CAS  PubMed  Google Scholar 

Rimland CA, et al. Outcome measures in large vessel vasculitis: relationship between patient-, physician-, imaging-, and laboratory-based assessments. Arthritis Care Res (Hoboken). 2020;72(9):1296–304.

Article  PubMed  PubMed Central  Google Scholar 

Kerr GS, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29.

Article  CAS  PubMed  Google Scholar 

Misra R, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford). 2013;52(10):1795–801.

Article  PubMed  Google Scholar 

Aydin SZ, et al. Assessment of disease activity and progression in Takayasu’s arteritis with Disease Extent Index-Takayasu. Rheumatology (Oxford). 2010;49(10):1889–93.

Article  PubMed  Google Scholar 

Boleto G, et al. Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review. J Rheumatol. 2023;50(6):789–98.

Article  PubMed  Google Scholar 

Alibaz-Oner F, et al. Assessment of patients with Takayasu arteritis in routine practice with Indian Takayasu Clinical Activity Score. J Rheumatol. 2015;42(8):1443–7.

Article  PubMed  Google Scholar 

Kwon OC, et al. Derivation and Validation of a New Disease Activity Assessment Tool With Higher Accuracy for Takayasu Arteritis. Front Immunol. 2022;13:925341.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goel R, et al. Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America. Rheumatology (Oxford). 2020;59(5):1118–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Misra DP, et al. Impact of geographic location on diagnosis and initial management of Takayasu arteritis: a tale of two cohorts from Italy and India. Diagnostics. 2022. https://doi.org/10.3390/diagnostics12123102.

Article  PubMed  PubMed Central  Google Scholar 

Marvisi C, et al. Development of the Takayasu arteritis integrated disease activity index. Arthritis Care Res (Hoboken). 2024;76(4):531–40.

Article  PubMed  PubMed Central  Google Scholar 

Langford CA, et al. A randomized, double-blind trial of Abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheum. 2017;69(4):846–53.

Article  CAS  Google Scholar 

Nakaoka Y, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2018;77(3):348–54.

Article  CAS  PubMed  Google Scholar 

Misra DP, et al. Outcome measures and biomarkers for disease assessment in Takayasu arteritis. Diagnostics. 2022;12(10):2565.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Q, et al. Pentraxin 3: A promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2020;19(12):102584.

Article  CAS  PubMed  Google Scholar 

Wen X, et al. Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: a systematic review and meta-analysis. PLoS One. 2021;16(2):e0245612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J. Association between acute phase reactants, interleukin-6, tumor necrosis factor-alpha, and disease activity in Takayasu’s arteritis patients. Arthritis Res Ther. 2020;22(1):285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian Y, et al. Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu’s arteritis patients. Arthritis Res Ther. 2021;23(1):303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaymaz-Tahra S, et al. Assessment of damage in Takayasu’s arteritis. Semin Arthritis Rheum. 2020;50(4):586–91.

Article  PubMed  Google Scholar 

Omma A, et al. Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort. Clin Exp Rheumatol. 2017;35(Suppl 103):77–82.

PubMed  Google Scholar 

Luna-Vargas L, et al. Takayasu’s arteritis from the patients’ perspectives: measuring the pulse to the patient-reported outcomes. Ann Vasc Surg. 2021;73:314–20.

Article  PubMed  Google Scholar 

Yoshifuji H, et al. Organ damage and quality of life in Takayasu arteritis　- evidence from a national registry analysis. Circ J. 2024;88(3):285–94.

Article  CAS  PubMed  Google Scholar 

Exley AR, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40(2):371–80.

Article  CAS  PubMed  Google